• 4-Ethylphenyl Sulfate: Evidence and Limits

  2026-10-13

  4-Ethylphenyl sulfate is described by a commercial supplier as a microbiota-derived metabolite, uremic toxin, and possible renal dysfunction biomarker. The supplied peer-reviewed study provides relevant context on adsorption of uremic toxins to cyclodextrin-coated magnetic nano-adsorbents, but its summary does not establish that 4-ethylphenyl sulfate was individually tested or that the findings apply to neurological or clinical outcomes. The evidence therefore supports a cautious research context, not a validated biomarker claim or therapeutic conclusion.

• TEV Protease and Cas13d: Evidence Boundaries

  2026-10-12

  TEV Protease and stimulus-controlled Cas13d address different biological problems: recombinant protein tag removal versus programmable RNA cleavage. The supplied evidence supports a conceptual distinction, not a head-to-head comparison. Zhu et al. report allosterically regulated RfxCas13d variants, while APExBIO presents TEV Protease as a protein purification enzyme; compatibility, construct effects, specificity, stability and cross-context performance remain untested.

• N2703 and the Adipose–Neural Axis: Evidence Review

  2026-10-12

  A source-grounded overview of the proposed leptin–NPY pathway in cardiac arrhythmia research, with careful separation of findings from product-level claims about 3-(1-methylpyrrolidin-2-yl)pyridine (N2703).

• GSK621: AMPK Signaling at the Immunometabolic Crossroads

  2026-10-11

  GSK621 is more than a conventional AMPK agonist: it is a research tool for testing how energy-sensing signals reshape leukemia biology, autophagy, lipid metabolism, apoptosis, and the tumor immune microenvironment. This article connects catalog-reported AML findings with Xiao et al.’s 2024 Immunity study on the 25-hydroxycholesterol–AMPK–STAT6 axis in tumor-associated macrophages, while emphasizing evidence boundaries, translational questions, and the risks of treating AMPK activation as a universally beneficial intervention.

• Dihydrotestosterone: Research Context and Evidence

  2026-10-10

  Dihydrotestosterone (DHT) is a potent androgen-receptor agonist used to study androgen-dependent biology. This overview compares evidence from prostate, bladder cancer, and ALS-related models while distinguishing peer-reviewed findings from supplier-reported claims and outlining key translational limits.

• Clathrin-Mediated Entry of Grass Carp Reovirus

  2026-10-09

  Wang et al. used complementary inhibitor profiling, transmission electron microscopy, and quantitative PCR to examine how genotype III grass carp reovirus enters CIK cells. Their findings support a dynamin-dependent, clathrin-mediated and pH-dependent endocytic route, while the lack of an apparent effect from Latrunculin B argues against a requirement for actin polymerization in this specific entry model.

• Chloroquine Diphosphate in Cancer Research

  2026-10-09

  Chloroquine diphosphate is a pharmacological tool for studying lysosomal function, autophagic flux, and treatment resistance. This overview separates supplier claims from findings in colorectal cancer research and explains what the evidence can—and cannot—support regarding chemotherapy sensitization, radiotherapy sensitization, and translational use.

• CAR-M Immunotherapy in Hepatocellular Carcinoma

  2026-10-08

  A source-grounded overview of an early preclinical CAR-macrophage strategy for hepatocellular carcinoma. The analysis distinguishes reported findings from interpretation, compares mechanistic, cellular, and tumor-model evidence, and outlines limitations that prevent clinical or cross-domain extrapolation.

• GSK621: AMPK Agonist Evidence and Limits

  2026-10-07

  GSK621 is a research-grade AMPK agonist linked to AMPKα T172 signaling, downstream metabolic regulation, and reported activity in acute myeloid leukemia models. This article separates product-dossier claims from peer-reviewed evidence on 25-hydroxycholesterol, AMPK, and tumor-associated macrophages.

• Alkaline Phosphatase Substrate Test Kit Overview

  2026-10-07

  A source-limited overview of APExBIO’s K4151 BCIP/NBT substrate kit for conceptual alkaline phosphatase activity detection. No matched paper evidence was supplied, so application-specific performance remains unverified.

• (R)-MG132 and the Logic of Causal Control

  2026-10-06

  A translational framework for using (R)-MG132 as a stereochemical negative control when evaluating proteasome-dependent mechanisms in cancer metabolism, with specific relevance to the HNRNPU K181 lactylation–PHGDH axis reported in cervical cancer.

• Aurora A in Retinoblastoma: Evidence for Targeted Therapy

  2026-10-06

  A 2024 American Journal of Pathology study reports that Aurora kinase A is overexpressed in human retinoblastoma and associated with histopathologic features linked to higher metastatic risk. By combining patient specimens with cellular, patient-derived, xenograft, and pharmacologic evidence, the study supports AURKA as a biologically relevant therapeutic target while leaving clinical efficacy and delivery questions unresolved.

• T7 RNA Polymerase in RNA-Responsive Research

  2026-10-05

  T7 RNA Polymerase is a promoter-specific, DNA-dependent enzyme widely used for research RNA synthesis. This overview examines its evidence base, conceptual relevance to RNA-responsive pyroptosis research, potential applications, and important boundaries between commercial product claims and peer-reviewed findings.

• T7 RNA Polymerase: From Synthesis to Delivery

  2026-10-05

  T7 RNA Polymerase is a precise in vitro transcription enzyme for defined RNA production. This article connects its upstream synthesis role with new evidence on lipid nanoparticle trafficking, clarifying why RNA quality and intracellular delivery must be interpreted as separate research questions.

• STING agonist-1: Interpreting Immune Signaling

  2026-10-04

  STING agonist-1 is a small-molecule immunology research reagent for examining innate immune signaling. This article connects its catalog-defined activity with the 2025 ESCC tertiary lymphoid structure study while separating mechanistic interpretation from direct evidence.

8380 records 2/559 page Previous Next 12345 下5页 Last page